Out-licensing: Erythropoietin

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Out-licensing
View

Erythropoietin

rHu EPO

Mechanism of action

Stimulates erythropoiesis by enhancing the mitotic frequency of late erythroid precurssors in the bone marrow

Full description

Fully-developed technology for manufacture of recombinant human erythropoietin (EPO)

High yielding process.
Quality matching branded product.
CHO based expression.
Product under clinical trials in India.
Unlimited supplies will be available for bulk and finished product in pre-filled syringes.
Technical documents are available for registration.

Development status

Phase III

Patent information

Patent number :1232/MUM/2007

Patent title :Process for the production of isoforms of recombinant human erythropoietin

Type of business relationship sought

Out-licensing of technology for recombinant EPO derived from CHO *Scouting for a business partner, who would register, import, promote and sell the product (bulk and finish formulation in PFS) in predecided territories globally. * Marketing tie-ups.

Patent number

1232/MUM/2007

Licensing contact

Mr. Milan Doshi
Asst General Manager
Business Development

Contact directly

Company details

Intas BioPharmaceuticals

Research driven, human biotherapeutics company focused on rDNA products offering out-licensing of biogeneric bulk-API and finished formulations, contract research and contract manufacturing services.

View profile

Visit website

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

BIO-011 - INFLAMMATION - Preventing IL-2 Mediated Inflammation in Epithelial Cells

BIO-012 - CARDIOVASCULAR DISEASE - Novel Pharmacological Approach for the Control of Homocysteine Levels in Patients with End-Stage Renal Disease

Phytohealth Corporation: PH3 (PHN031, PHN033) - For osteoporosis and diabetic vascular complications

Uses of Type IV Collagen in regeneration and restoration of renal cell injury (02-28)

Related categories

Industry sector: Biotechnology / Human therapeutics; Biotechnology / Manufacturing; Service / Manufacturing; Biotechnology / Research supplies
Therapeutic target: Cardiovascular / Anemia; Oncology / Treatments / Chemotherapy; Hospital and Surgery / Dialysis; Genito-urinary / Urinary / Dialysis; Genito-urinary / Urinary / Kidney disorder (other); Genito-urinary / Urinary / Renal disease; Genito-urinary / Urinary / Renal failure; Hospital and Surgery / Surgery (other)

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us